Free Trial
NASDAQ:PETV

PetVivo (PETV) Stock Price, News & Analysis

PetVivo logo
$0.80 +0.04 (+5.28%)
As of 05/23/2025 03:59 PM Eastern

About PetVivo Stock (NASDAQ:PETV)

Key Stats

Today's Range
$0.71
$0.80
50-Day Range
$0.49
$0.86
52-Week Range
$0.29
$0.98
Volume
22,782 shs
Average Volume
20,434 shs
Market Capitalization
$19.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Receive PETV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetVivo and its competitors with MarketBeat's FREE daily newsletter.

PETV Stock News Headlines

Market chaos is the new normal
It happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, laptops, and semiconductors. Tech stocks surged—but not because the economy is stable. It’s because investors are panicking over trade policy whiplash. And here’s the hard truth: If your retirement is too tied to stocks, you’re exposed.
PetVivo closes Series B Convertible Preferred Stock offering
See More Headlines

PETV Stock Analysis - Frequently Asked Questions

PetVivo's stock was trading at $0.62 at the beginning of 2025. Since then, PETV shares have increased by 29.0% and is now trading at $0.80.
View the best growth stocks for 2025 here
.

PetVivo Holdings, Inc. (NASDAQ:PETV) released its quarterly earnings results on Thursday, June, 29th. The company reported ($0.21) EPS for the quarter, hitting analysts' consensus estimates of ($0.21). The company had revenue of $0.13 million for the quarter. PetVivo had a negative net margin of 902.82% and a negative trailing twelve-month return on equity of 4,813.07%.

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

Last Earnings
6/29/2023
Today
5/24/2025
Next Earnings (Estimated)
6/26/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PETV
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,950,000.00
Net Margins
-902.82%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.05 million
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
-26.67

Miscellaneous

Free Float
19,057,000
Market Cap
$19.39 million
Optionable
Not Optionable
Beta
0.78
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:PETV) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners